Business Description
Sumitomo Pharma Co Ltd
NAICS : 325412
ISIN : JP3495000006
Description
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.09 | |||||
Equity-to-Asset | 0.17 | |||||
Debt-to-Equity | 2.68 | |||||
Debt-to-EBITDA | -1.59 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -1.02 | |||||
Beneish M-Score | -2.98 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -15.2 | |||||
3-Year Book Growth Rate | -35.5 | |||||
Future 3-5Y Total Revenue Growth Rate | 4.75 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 68.57 | |||||
9-Day RSI | 51.4 | |||||
14-Day RSI | 45.58 | |||||
6-1 Month Momentum % | -21.47 | |||||
12-1 Month Momentum % | -41.99 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.52 | |||||
Quick Ratio | 0.3 | |||||
Cash Ratio | 0.07 | |||||
Days Inventory | 301.98 | |||||
Days Sales Outstanding | 107 | |||||
Days Payable | 158.19 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -99.7 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 59.76 | |||||
Operating Margin % | -112.81 | |||||
Net Margin % | -100.13 | |||||
FCF Margin % | -81.9 | |||||
ROE % | -90.75 | |||||
ROA % | -29.21 | |||||
ROIC % | -30.98 | |||||
ROC (Joel Greenblatt) % | -461.44 | |||||
ROCE % | -45.12 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.42 | |||||
PB Ratio | 0.84 | |||||
EV-to-EBIT | -1.7 | |||||
EV-to-Forward-EBIT | -8.05 | |||||
EV-to-EBITDA | -1.94 | |||||
EV-to-Forward-EBITDA | 16.99 | |||||
EV-to-Revenue | 1.63 | |||||
EV-to-Forward-Revenue | 1.27 | |||||
EV-to-FCF | -1.96 | |||||
Price-to-Projected-FCF | 1.21 | |||||
Price-to-Median-PS-Value | 0.29 | |||||
Earnings Yield (Greenblatt) % | -58.81 | |||||
FCF Yield % | -197.7 | |||||
Forward Rate of Return (Yacktman) % | 36 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Sumitomo Pharma Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil 円) | 314,558 | ||
EPS (TTM) (円) | -792.785 | ||
Beta | 0 | ||
Volatility % | 33.01 | ||
14-Day RSI | 45.58 | ||
14-Day ATR (円) | 18.346837 | ||
20-Day SMA (円) | 337.65 | ||
12-1 Month Momentum % | -41.99 | ||
52-Week Range (円) | 279 - 692.5 | ||
Shares Outstanding (Mil) | 397.29 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Sumitomo Pharma Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Sumitomo Pharma Co Ltd Stock Events
Event | Date | Price(円) | ||
---|---|---|---|---|
No Event Data |
Sumitomo Pharma Co Ltd Frequently Asked Questions
What is Sumitomo Pharma Co Ltd(TSE:4506)'s stock price today?
When is next earnings date of Sumitomo Pharma Co Ltd(TSE:4506)?
Does Sumitomo Pharma Co Ltd(TSE:4506) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |